Keyphrases
Clinical High Risk
100%
Fluconazole
100%
Mycoses
100%
New Antifungal Agents
100%
Micafungin
42%
Hematopoietic Stem Cell Transplantation
42%
Haematopoietic Stem Cell Transplant Recipients
42%
Liver Stem Cells
42%
Pancreas
28%
Posaconazole
28%
Itraconazole
28%
Pre-engraftment
28%
Clinical Trials
14%
Graft-versus-host Disease (GvHD)
14%
Invasive Fungal Infection
14%
Lung Transplantation
14%
Fluconazole Prophylaxis
14%
Metabolism
14%
Cyclophosphamide
14%
Fungal Pathogens
14%
Antifungal Therapy
14%
Aerosolized
14%
Fungal Infection
14%
Amphotericin B
14%
High Morbidity
14%
Chemoprophylaxis
14%
Antifungal Prophylaxis
14%
Prolonged Immunosuppression
14%
Mold Infection
14%
Yeast Infection
14%
Gastrointestinal Side Effects
14%
Immunology and Microbiology
Hematopoietic Stem Cell Transplantation
100%
Engraftment
33%
Mould
33%
Pancreas
33%
Graft-Versus-Host Disease
16%
Immunosuppression
16%
Infectious Agent
16%
Cyclophosphamide
16%
Lung Transplantation
16%